Displaying drugs 1876 - 1900 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Entrectinib | 560.65 C31H34F2N6O2 |  | Entrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment... | Protein Kinase Inhibitors |
| Entecavir | 277.2792 C12H15N5O3 |  | A nucleoside analogue used in the treatment of chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. | Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Entacapone | 305.286 C14H15N3O5 |  | A selective reversible catechol-O-methyltransferase inhibitor for the treatment of Parkinson's disease. | Anti-Parkinson Drugs |
| Ensulizole | 274.29 C13H10N2O3S |  | An ingredient used in sunscreens to absorb UVB radiation. | Acids / Acids, Noncarboxylic / Heterocyclic Compounds, Fused-Ring / Sulfur Acids / Sulfur Compounds / Sunscreen Agents |
| Enprofylline | 194.1906 C8H10N4O2 |  | Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. | Adenosine A2 Receptor Antagonists / Anti-Asthmatic Agents / Bronchodilator Agents |
| Enoximone | 248.301 C12H12N2O2S |  | A selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure. | Phosphodiesterase Inhibitors |
| Enoxaparin | Not Available |  | A low molecular weight heparin used for the prophylaxis of deep vein thrombosis and ischemic complications of unstable angina and non-Q-wave myocardial infarction. | Heparin Group |
| Enoxacin | 320.3189 C15H17FN4O3 |  | For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria... | Anti-Bacterial Agents |
| Enmetazobactam | 314.32 C11H14N4O5S |  | A beta-lactamase inhibitor used to treat complicated urinary tract infections in combination with cefepime. | beta-Lactamase Inhibitors |
| Enflurane | 184.492 C3H2ClF5O |  | A halogenated inhalational anesthetic agent used for the induction and maintenance of anesthesia and for analgesia during labor and delivery. | Anesthetics, General / Anesthetics, Inhalation / Methyl Ethers |
| Encorafenib | 540.01 C22H27ClFN7O4S |  | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Encainide | 352.4699 C22H28N2O2 |  | A voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ventricular tachycardia, that is no longer used due to proarrhythmic adverse effects. | Antiarrhythmic agents / Antiarrhythmics, Class Ic |
| Enasidenib | 473.383 C19H17F6N7O |  | An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. | Isocitrate Dehydrogenase 2 Inhibitor |
| Enalaprilat | 348.3936 C18H24N2O5 |  | An antihypertensive agent used for the management of hypertension when oral therapy is not practical. | Angiotensin-Converting Enzyme Inhibitors / Antihypertensive Agents / Antihypertensive Agents Indicated for Hypertension / Drugs causing inadvertant photosensitivity |
| Enalapril | 376.4467 C20H28N2O5 |  | A prodrug of an ACE inhibitor used to treat hypertension and congestive heart failure. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics |
| Emtricitabine | 247.247 C8H10FN3O3S |  | A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. | Anti-HIV Agents / Antiviral Agents / Deoxycytidine / Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Nucleoside and Nucleotide Reverse Transcriptase Inhibitors / Reverse Transcriptase Inhibitors |
| Empagliflozin | 450.91 C23H27ClO7 |  | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Emedastine | 302.4145 C17H26N4O |  | A selective H1-receptor antagonist used topically to manage symptoms of allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists / Histamine H1 Inhibitors |
| Elvitegravir | 447.884 C23H23ClFNO5 |  | An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. | Anti-HIV Agents / Anti-Retroviral Agents / HIV Integrase / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / Integrase Inhibitors |
| Eluxadoline | 569.662 C32H35N5O5 |  | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Eltrombopag | 442.4666 C25H22N4O4 |  | A thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. | Thrombopoietin Receptor Agonist |
| Eliglustat | 404.551 C23H36N2O4 |  | A glucosylceramide synthase used to treat type 1 Gaucher disease in patients who are CYP2D6 extensive, intermediate, or poor metabolizers. | Various Alimentary Tract and Metabolism Products |
| Elexacaftor | 597.66 C26H34F3N7O4S |  | A small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. | Cystic Fibrosis Transmembrane Conductance Regulator Correctors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Membrane Transport Modulators / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
| Eletriptan | 382.519 C22H26N2O2S |  | A triptan used for the treatment of migraines. | Selective Serotonin 5-HT1 Receptor Agonists / Serotonin Receptor Agonists |
| Elbasvir | 882.035 C49H55N9O7 |  | An antiviral and NS5A inhibitor used to treat hepatitis C infections. | Antivirals for treatment of HCV infections |
Displaying drugs 1876 - 1900 of 2779 in total